Daniel Markovich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Markovich has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Paul Anthony Dawson
Department of Food, Nutrition and Packaging Sciences, Clemson University, Clemson, SC 29634, USA
8 shared publications - Karl Kunzelmann
Physiological institute, University of Regensburg, Regensburg, Germany
3 shared publications - Sarah Elizabeth Steane
Mater Research Institute, University of Queensland, Brisbane, QLD, Australia
3 shared publications Soohyun Lee
School of Biomedical Sciences, University of Queensland, Brisbane, Australia. 2Department of Medical Genetics and the Child and Family Research Institute, University Of British Columbia, Vancouver, Canada. 3Pathology Department, Mater Misercordiae Hospital, South Brisbane, Australia
3 shared publicationsHeini Murer
University of Zürich
2 shared publicationsKatrina J. Pirlo
School of Biomedical Sciences, University of Queensland
2 shared publications
Latest Publications
- 1 February 2012
- Published by American Physiological Society in Physiology
- Vol. 27 (1) , 7-14
Slc13a1 and Slc26a1 KO Models Reveal Physiological Roles of Anion Transporters
Anion transporters NaS1 (SLC13A1) and Sat1 (SLC26A1) mediate sulfate (re)absorption across renal proximal tubule and small intestinal epithelia, thereby regulating blood sulfate levels. Disruption of murine NaS1 and Sat1 genes leads to hyposulfatemia and hypersulfaturia. Sat1-null mice also exhibit hyperoxalemia, hyperoxaluria, and calcium oxalate urolithiasis. This review will highlight the current pathophysiological features of NaS1- and Sat1-null mice resulting from alterations in circulating sulfate and oxalate anion levels.
- 1 February 2012
- Published by American Physiological Society in Physiology
- Vol. 27 (1) , 7-14
Slc13a1 and Slc26a1 KO Models Reveal Physiological Roles of Anion Transporters
Anion transporters NaS1 (SLC13A1) and Sat1 (SLC26A1) mediate sulfate (re)absorption across renal proximal tubule and small intestinal epithelia, thereby regulating blood sulfate levels. Disruption of murine NaS1 and Sat1 genes leads to hyposulfatemia and hypersulfaturia. Sat1-null mice also exhibit hyperoxalemia, hyperoxaluria, and calcium oxalate urolithiasis. This review will highlight the current pathophysiological features of NaS1- and Sat1-null mice resulting from alterations in circulating sulfate and oxalate anion levels.
- 1 January 2012
- Published by Elsevier
- Vol. 70, 239-256
Sodium-Sulfate/Carboxylate Cotransporters (SLC13)
- 1 January 2012
- Published by Elsevier
- Vol. 70, 239-256
Sodium-Sulfate/Carboxylate Cotransporters (SLC13)
- 1 October 2011
- Published by Elsevier in Experimental Gerontology
- Vol. 46 (10) , 833-835
Increased lifespan in hyposulfatemic NaS1 null mice
- 1 October 2011
- Published by Elsevier in Experimental Gerontology
- Vol. 46 (10) , 833-835
Increased lifespan in hyposulfatemic NaS1 null mice
- 1 June 2011
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 300 (6) , F1267-F1270
Physiological roles of renal anion transporters NaS1 and Sat1
This review will briefly summarize current knowledge on the renal anion transporters sodium-sulfate cotransporter-1 (NaS1; Slc13a1) and sulfate-anion transporter-1 (Sat1; Slc26a1). NaS1 and Sat1 mediate renal proximal tubular sulfate reabsorption and thereby regulate blood sulfate levels. Sat1 also mediates renal oxalate transport and controls blood oxalate levels. Targeted disruption of murine NaS1 and Sat1 leads to hyposulfatemia and hypersulfaturia. Sat1 null mice also exhibit hyperoxalemia, hyperoxaluria, and calcium oxalate urolithiasis. NaS1 and Sat1 null mice also have other phenotypes that result due to changes in blood sulfate and oxalate levels. Experimental data indicate that NaS1 is essential for maintaining sulfate homeostasis, whereas Sat1 controls both sulfate and oxalate homeostasis in vivo.
- 1 June 2011
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 300 (6) , F1267-F1270
Physiological roles of renal anion transporters NaS1 and Sat1
This review will briefly summarize current knowledge on the renal anion transporters sodium-sulfate cotransporter-1 (NaS1; Slc13a1) and sulfate-anion transporter-1 (Sat1; Slc26a1). NaS1 and Sat1 mediate renal proximal tubular sulfate reabsorption and thereby regulate blood sulfate levels. Sat1 also mediates renal oxalate transport and controls blood oxalate levels. Targeted disruption of murine NaS1 and Sat1 leads to hyposulfatemia and hypersulfaturia. Sat1 null mice also exhibit hyperoxalemia, hyperoxaluria, and calcium oxalate urolithiasis. NaS1 and Sat1 null mice also have other phenotypes that result due to changes in blood sulfate and oxalate levels. Experimental data indicate that NaS1 is essential for maintaining sulfate homeostasis, whereas Sat1 controls both sulfate and oxalate homeostasis in vivo.
- 6 February 2011
- Published by Walter de Gruyter GmbH in Archivum Immunologiae et Therapiae Experimentalis
- Vol. 59 (2) , 113-116
Physiological Roles of Mammalian Sulfate Transporters NaS1 and Sat1
This review summarizes the physiological roles of the renal sulfate transporters NaS1 (Slc13a1) and Sat1 (Slc26a1). NaS1 and Sat1 encode renal anion transporters that mediate proximal tubular sulfate reabsorption and thereby regulate blood sulfate levels. Targeted disruption of murine NaS1 and Sat1 leads to hyposulfatemia and hypersulfaturia. Sat1 null mice also exhibit hyperoxalemia, hyperoxaluria and calcium oxalate urolithiasis. Dysregulation of NaS1 and Sat1 leads to hypersulfaturia, hyposulfatemia and liver damage. Loss of Sat1 leads additionally to hyperoxaluria with hyperoxalemia, nephrocalcinosis and calcium oxalate urolithiasis. These data indicate that the renal anion transporters NaS1 and Sat1 are essential for sulfate and oxalate homeostasis, respectively.
- 6 February 2011
- Published by Walter de Gruyter GmbH in Archivum Immunologiae et Therapiae Experimentalis
- Vol. 59 (2) , 113-116
Physiological Roles of Mammalian Sulfate Transporters NaS1 and Sat1
This review summarizes the physiological roles of the renal sulfate transporters NaS1 (Slc13a1) and Sat1 (Slc26a1). NaS1 and Sat1 encode renal anion transporters that mediate proximal tubular sulfate reabsorption and thereby regulate blood sulfate levels. Targeted disruption of murine NaS1 and Sat1 leads to hyposulfatemia and hypersulfaturia. Sat1 null mice also exhibit hyperoxalemia, hyperoxaluria and calcium oxalate urolithiasis. Dysregulation of NaS1 and Sat1 leads to hypersulfaturia, hyposulfatemia and liver damage. Loss of Sat1 leads additionally to hyperoxaluria with hyperoxalemia, nephrocalcinosis and calcium oxalate urolithiasis. These data indicate that the renal anion transporters NaS1 and Sat1 are essential for sulfate and oxalate homeostasis, respectively.
- Open Access
- 1 March 2010
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 120 (3) , 706-712
Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice
Urolithiasis, a condition in which stones are present in the urinary system, including the kidneys and bladder, is a poorly understood yet common disorder worldwide that leads to significant health care costs, morbidity, and work loss. Acetaminophen-induced liver damage is a major cause of death in patients with acute liver failure. Kidney and urinary stones and liver toxicity are disturbances linked to alterations in oxalate and sulfate homeostasis, respectively. The sulfate anion transporter–1 (Sat1; also known as Slc26a1) mediates epithelial transport of oxalate and sulfate, and its localization in the kidney, liver, and intestine suggests that it may play a role in oxalate and sulfate homeostasis. To determine the physiological roles of Sat1, we created Sat1–/– mice by gene disruption. These mice exhibited hyperoxaluria with hyperoxalemia, nephrocalcinosis, and calcium oxalate stones in their renal tubules and bladder. Sat1–/– mice also displayed hypersulfaturia, hyposulfatemia, and enhanced acetaminophen-induced liver toxicity. These data suggest that Sat1 regulates both oxalate and sulfate homeostasis and may be critical to the development of calcium oxalate urolithiasis and hepatotoxicity.
- 1 March 2010
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 120 (3) , 706-712
Open AccessUrolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice
Urolithiasis, a condition in which stones are present in the urinary system, including the kidneys and bladder, is a poorly understood yet common disorder worldwide that leads to significant health care costs, morbidity, and work loss. Acetaminophen-induced liver damage is a major cause of death in patients with acute liver failure. Kidney and urinary stones and liver toxicity are disturbances linked to alterations in oxalate and sulfate homeostasis, respectively. The sulfate anion transporter–1 (Sat1; also known as Slc26a1) mediates epithelial transport of oxalate and sulfate, and its localization in the kidney, liver, and intestine suggests that it may play a role in oxalate and sulfate homeostasis. To determine the physiological roles of Sat1, we created Sat1–/– mice by gene disruption. These mice exhibited hyperoxaluria with hyperoxalemia, nephrocalcinosis, and calcium oxalate stones in their renal tubules and bladder. Sat1–/– mice also displayed hypersulfaturia, hyposulfatemia, and enhanced acetaminophen-induced liver toxicity. These data suggest that Sat1 regulates both oxalate and sulfate homeostasis and may be critical to the development of calcium oxalate urolithiasis and hepatotoxicity.
- 29 January 2010
- Published by Wiley in Cancer Science
- Vol. 101 (2) , 369-373
Enhanced tumor growth in the NaS1 sulfate transporter null mouse
Sulfate plays an important role in maintaining normal structure and function of tissues, and its content is decreased in certain cancers including lung carcinoma. In this study, we investigated tumor growth in a mouse model of hyposulfatemia (Nas1−/−) and compared it to wild‐type (Nas1+/+) mice. Lung epithelial tumor cells (TC‐1 cell line) were injected subcutaneously into male Nas1−/− and Nas1+/+ mice on a mixed 129Sv and C57BL/6 genetic background. Tumor sections were stained with anti‐glycosaminoglycan antibodies to assess the distribution of proteoglycans and Gomori’s trichrome to detect collagen. After 14 days, tumor weights were markedly increased (by ∼12‐fold) in Nas1−/− mice when compared with Nas1+/+ mice. Histological analyses of tumors revealed increased (by ≈2.4‐fold) vessel content, as well as markedly reduced collagen and immunoreactivity against glycosaminoglycan structural epitopes in the tumors from Nas1−/− mice. No significant differences were found for the growth of cultured TC‐1 cells supplemented with Nas1−/− or Nas1+/+ serum, as determined by 3H‐thymidine incorporation, implying that the cell culture conditions may not reflect the in vivo situation of enhanced tumor growth. This study has revealed increased tumor growth and an altered extracellular tumor matrix in hyposulfatemic Nas1−/− mice. These findings highlight the importance of blood sulfate levels as a possible modulator of tumor growth, and could lead to future cancer studies in humans with altered sulfate homeostasis. (Cancer Sci 2009; 00: 000–000)
- 29 January 2010
- Published by Wiley in Cancer Science
- Vol. 101 (2) , 369-373
Enhanced tumor growth in the NaS1 sulfate transporter null mouse
Sulfate plays an important role in maintaining normal structure and function of tissues, and its content is decreased in certain cancers including lung carcinoma. In this study, we investigated tumor growth in a mouse model of hyposulfatemia (Nas1−/−) and compared it to wild‐type (Nas1+/+) mice. Lung epithelial tumor cells (TC‐1 cell line) were injected subcutaneously into male Nas1−/− and Nas1+/+ mice on a mixed 129Sv and C57BL/6 genetic background. Tumor sections were stained with anti‐glycosaminoglycan antibodies to assess the distribution of proteoglycans and Gomori’s trichrome to detect collagen. After 14 days, tumor weights were markedly increased (by ∼12‐fold) in Nas1−/− mice when compared with Nas1+/+ mice. Histological analyses of tumors revealed increased (by ≈2.4‐fold) vessel content, as well as markedly reduced collagen and immunoreactivity against glycosaminoglycan structural epitopes in the tumors from Nas1−/− mice. No significant differences were found for the growth of cultured TC‐1 cells supplemented with Nas1−/− or Nas1+/+ serum, as determined by 3H‐thymidine incorporation, implying that the cell culture conditions may not reflect the in vivo situation of enhanced tumor growth. This study has revealed increased tumor growth and an altered extracellular tumor matrix in hyposulfatemic Nas1−/− mice. These findings highlight the importance of blood sulfate levels as a possible modulator of tumor growth, and could lead to future cancer studies in humans with altered sulfate homeostasis. (Cancer Sci 2009; 00: 000–000)
- 15 October 2009
- Published by Springer Nature
- p. 165-193
Sulfate and Phosphate Transporters in Mammalian Renal and Gastrointestinal Systems
- 15 October 2009
- Published by Springer Nature
- p. 165-193
Sulfate and Phosphate Transporters in Mammalian Renal and Gastrointestinal Systems
- 4 December 2008
- Published by Springer Nature in Nature Protocols
- Vol. 3 (12) , 1975-1980
Expression cloning and radiotracer uptakes in Xenopus laevis oocytes
This protocol describes the method of expression cloning of heterologous proteins using Xenopus laevis oocytes and the functional characterization of membrane proteins using radiotracer assays. It can be used to isolate proteins for which sequence data is unavailable and to characterize the functions of proteins. A cDNA library is generated, that is, translated into proteins in Xenopus oocytes, and the function of these proteins is assessed by a radiotracer assay. Their large size, high degree of expression and ease of handling makes Xenopus oocytes an optimal tool for the expression and characterization of protein function when compared with traditional expression systems, such as Escherichia coli, yeast or eukaryotic cell lines. The expected results of this technique include the following: functional identification of novel proteins; molecular (kinetic) characterization of protein function; and determination of functionally relevant residues and domains of membrane proteins, including transporters, ion channels and receptors. The identification of novel proteins can take several months, whereas functional characterization in Xenopus oocytes can take 1 week.
- 4 December 2008
- Published by Springer Nature in Nature Protocols
- Vol. 3 (12) , 1975-1980
Expression cloning and radiotracer uptakes in Xenopus laevis oocytes
This protocol describes the method of expression cloning of heterologous proteins using Xenopus laevis oocytes and the functional characterization of membrane proteins using radiotracer assays. It can be used to isolate proteins for which sequence data is unavailable and to characterize the functions of proteins. A cDNA library is generated, that is, translated into proteins in Xenopus oocytes, and the function of these proteins is assessed by a radiotracer assay. Their large size, high degree of expression and ease of handling makes Xenopus oocytes an optimal tool for the expression and characterization of protein function when compared with traditional expression systems, such as Escherichia coli, yeast or eukaryotic cell lines. The expected results of this technique include the following: functional identification of novel proteins; molecular (kinetic) characterization of protein function; and determination of functionally relevant residues and domains of membrane proteins, including transporters, ion channels and receptors. The identification of novel proteins can take several months, whereas functional characterization in Xenopus oocytes can take 1 week.
- 1 August 2008
- Published by American Physiological Society in Physiological Genomics
- Vol. 34 (3) , 256-264
Functional and structural characterization of the zebrafish Na+-sulfate cotransporter 1 (NaS1) cDNA and gene (slc13a1)
Sulfate plays an essential role during growth, development and cellular metabolism. In this study, we characterized the function and structure of the zebrafish ( Danio rerio) Na+-sulfate cotransporter 1 (NaS1) cDNA and gene ( slc13a1). Zebrafish NaS1 encodes a protein of 583 amino acids with 13 putative transmembrane domains. Expression of zebrafish NaS1 protein in Xenopus oocytes led to Na+-sulfate cotransport, which was significantly inhibited by thiosulfate, selenate, molybdate, and tungstate. Zebrafish NaS1 transport kinetics were: Vmax = 1,731.670 ± 92.853 pmol sulfate/oocyte·hour and Km = 1.414 ± 0.275 mM for sulfate and Vmax = 307.016 ± 32.992 pmol sulfate/oocyte·hour, Km = 24.582 ± 4.547 mM and n (Hill coefficient) = 1.624 ± 0.354 for sodium. Zebrafish NaS1 mRNA is developmentally expressed in embryos from day 1 postfertilization and in the intestine, kidney, brain, and eye of adult zebrafish. The zebrafish NaS1 gene slc13a1 contains 15 exons spanning 8,716 bp. Characterization of the zebrafish NaS1 contributes to a greater understanding of sulfate transporters in a well-defined genetic model and will allow the elucidation of evolutionary and functional relationships among vertebrate sulfate transporters.
- 1 August 2008
- Published by American Physiological Society in Physiological Genomics
- Vol. 34 (3) , 256-264
Functional and structural characterization of the zebrafish Na+-sulfate cotransporter 1 (NaS1) cDNA and gene (slc13a1)
Sulfate plays an essential role during growth, development and cellular metabolism. In this study, we characterized the function and structure of the zebrafish ( Danio rerio) Na+-sulfate cotransporter 1 (NaS1) cDNA and gene ( slc13a1). Zebrafish NaS1 encodes a protein of 583 amino acids with 13 putative transmembrane domains. Expression of zebrafish NaS1 protein in Xenopus oocytes led to Na+-sulfate cotransport, which was significantly inhibited by thiosulfate, selenate, molybdate, and tungstate. Zebrafish NaS1 transport kinetics were: Vmax = 1,731.670 ± 92.853 pmol sulfate/oocyte·hour and Km = 1.414 ± 0.275 mM for sulfate and Vmax = 307.016 ± 32.992 pmol sulfate/oocyte·hour, Km = 24.582 ± 4.547 mM and n (Hill coefficient) = 1.624 ± 0.354 for sodium. Zebrafish NaS1 mRNA is developmentally expressed in embryos from day 1 postfertilization and in the intestine, kidney, brain, and eye of adult zebrafish. The zebrafish NaS1 gene slc13a1 contains 15 exons spanning 8,716 bp. Characterization of the zebrafish NaS1 contributes to a greater understanding of sulfate transporters in a well-defined genetic model and will allow the elucidation of evolutionary and functional relationships among vertebrate sulfate transporters.